Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Région de Kantō222
Tsukasa Matsubara8
Région de Kantō Sauf Tsukasa Matsubara" 218
Tsukasa Matsubara Sauf Région de Kantō" 4
Région de Kantō Et Tsukasa Matsubara 4
Région de Kantō Ou Tsukasa Matsubara 226
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000E84 Hiroaki Matsuno [Japon] ; Kou Katayama [Japon] ; Keiko Funahashi [Japon] ; Makoto Saitoh [Japon] ; Tsukasa Matsubara [Japon]Choice of the most appropriate biological disease-modifying rheumatic drug for injection spacing: results from a multicentre observational study.
002819 Shigeki Momohara [Japon] ; Jun Hashimoto ; Hideki Tsuboi ; Hisaaki Miyahara ; Natsuko Nakagawa ; Atsushi Kaneko ; Naoki Kondo ; Hiroaki Matsuno ; Takahiko Wada ; Tohgo Nonaka ; Katsuaki Kanbe ; Haruki Takagi ; Akira Murasawa ; Tsukasa Matsubara ; Toru SuguroAnalysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.
003A57 Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
003F14 Ryuji Koike [Japon] ; Masayoshi Harigai ; Tatsuya Atsumi ; Koichi Amano ; Shinichi Kawai ; Kazuyoshi Saito ; Tomoyuki Saito ; Masahiro Yamamura ; Tsukasa Matsubara ; Nobuyuki MiyasakaJapan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021